Skip to main content

GOLDMAN SACHS GROUP INC

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in OLMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,615,416
+$4,025,685 QoQ
Shares Held
1,567,979
+50.0% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 182 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OLMA Over Time

Shares Held

Position Value (USD)

Derivatives in OLMA

reported options exposure · as of Mar 31, 2026
CallValue
$2,454,186
CallShares
164,600
PutValue
$633,675
PutShares
42,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. OLMA ranks #113 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OLMA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,615,416 1,567,979
2026-03-31 $633,675 42,500
2026-03-31 $2,454,186 164,600
2026-03-31 $15,589,731 1,045,589
2025-12-31 $20,447,225 817,889
2025-09-30 $7,869,994 803,881
2025-06-30 $3,086,718 724,582
2025-03-31 $2,787,395 741,329
2024-12-31 $2,232,405 382,917
2024-09-30 $5,520,422 462,347
2024-06-30 $4,339,955 401,105
2024-03-31 $4,947,190 437,031
2023-12-31 $4,426,155 315,478
2023-09-30 $1,160,096 93,935
2023-06-30 $333,974 36,985
2023-03-31 $141,905 40,895
2022-12-31 $78,382 31,993
2022-09-30 $521,664 189,009
2022-06-30 $835,558 205,297
2022-03-31 $1,899,738 445,948
2021-12-31 $2,036,735 217,600
2021-09-30 $4,151,058 150,619
2021-06-30 $1,374,153 49,112
2021-03-31 $700,131 21,101
2020-12-31 $2,652,333 55,165